Report cover image

Tissue Engineered - Skin Substitutes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Publisher GlobalData
Published May 20, 2022
Length 148 Pages
SKU # GBDT17278609

Description

Tissue Engineered - Skin Substitutes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Summary

GlobalData's Medical Devices sector report, “Tissue Engineered - Skin Substitutes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Tissue Engineered - Skin Substitutes pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Tissue engineering for wound care management is the use of mechanical and chemical processing of materials to manufacture products that may substitute or replace all or some components that make up a normal skin (e.g. epidermis and/or dermis, cells and matrix).

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Tissue Engineered - Skin Substitutes under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Tissue Engineered - Skin Substitutes and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to-
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Tissue Engineered - Skin Substitutes under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

148 Pages
  • About GlobalData
    • Tissue Engineered - Skin Substitutes Overview
    • Tissue Engineered - Skin Substitutes - Pipeline Products by Stage of Development
    • Tissue Engineered - Skin Substitutes - Pipeline Products by Segment
    • Tissue Engineered - Skin Substitutes - Pipeline Products by Territory
    • Tissue Engineered - Skin Substitutes - Pipeline Products by Regulatory Path
    • Tissue Engineered - Skin Substitutes - Pipeline Products by Estimated Approval Date
    • Tissue Engineered - Skin Substitutes - Ongoing Clinical Trials
    • Tissue Engineered - Skin Substitutes Companies - Pipeline Products by Stage of Development
    • Tissue Engineered - Skin Substitutes - Companies Pipeline Products by Stage of Development
    • Acro Biomedical Co Ltd Company Overview
    • Adept Medical Ltd Company Overview
    • AGAM Biological Products Company Overview
    • Agenta Biotechnologies Inc (Inactive) Company Overview
    • Amnio Technology LLC Company Overview
    • Boston Children's Hospital Company Overview
    • China Regenerative Medicine International Ltd Company Overview
    • Cutiss AG Company Overview
    • Elanix Biotechnologies AG Company Overview
    • Indian Institute of Technology Delhi Company Overview
    • Kerecis ehf Company Overview
    • Lattice Biologics Ltd Company Overview
    • LifeCell Corp Company Overview
    • Merakris Therapeutics LLC Company Overview
    • MiMedx Group Inc Company Overview
    • Novadip Biosciences SA Company Overview
    • Organogenesis Holdings Inc Company Overview
    • Osiris Therapeutics Inc Company Overview
    • PolarityTE Inc Company Overview
    • PolyNovo Biomaterials Pty Ltd Company Overview
    • Protein Genomics Inc Company Overview
    • Purdue University Company Overview
    • Regenicin Inc Company Overview
    • Rensselaer Polytechnic Institute Company Overview
    • ROKIT Healthcare Inc Company Overview
    • Santai Biotech Company Overview
    • Smith & Nephew Plc Company Overview
    • SMSbiotech Inc Company Overview
    • Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
    • Stratatech Corp Company Overview
    • Tel Aviv University Company Overview
    • Tissue Regenix Ltd Company Overview
    • University of Edinburgh Company Overview
    • Vericel Corp Company Overview
    • Worcester Polytechnic Institute Company Overview
    • XenoTherapeutics Inc Company Overview
    • May 10, 2022: Biostage Schedules Conference Call and Webcast for Q1 2022 Results
    • May 09, 2022: Anika to Participate in the UBS Global Healthcare Conference 2022
    • May 05, 2022: Anika Reports First Quarter Fiscal 2022 Financial Results
    • Apr 28, 2022: Orthofix Medical Schedules First Quarter Earnings Release and Conference Call for May 6, 2022
    • Apr 28, 2022: Smith+Nephew First Quarter 2022 Trading Update
    • Apr 08, 2022: Orthofix Announces New Business Unit President
    • Apr 07, 2022: Anika to Issue First Quarter 2022 Financial Results on Thursday, May 5, 2022
    • Apr 04, 2022: Anika to Participate in the 21st Annual Needham Virtual Healthcare Conference
    • Mar 31, 2022: Smith & Nephew announces Directorate Change
    • Mar 10, 2022: Anika to Participate in the Canaccord Genuity Musculoskeletal Conference
    • Mar 08, 2022: Anika Reports Fourth Quarter and Year-End 2021 Financial Results
    • Feb 28, 2022: MIMEDX Announces Fourth Quarter and Full Year 2021 Operating and Financial Results
    • Feb 22, 2022: Smith+nephew Announces New Chief Executive Officer
    • Feb 10, 2022: Orthofix Medical Schedules Fourth Quarter and Full Year Earnings Release and Conference Call for February 25 2022
    • Feb 08, 2022: Anika to Issue Fourth Quarter and Year-End 2021 Financial Results on Tuesday, March 8, 2022
    • Jan 25, 2022: Medprin Regenerative Medical Technologies Announces on the resignation of the company's director and board secretary
    • Jan 10, 2022: Orthofix Announces Preliminary 2021 Fourth Quarter and Full Year Net Sales Results
    • Dec 21, 2021: Maipu Medical Announcement on Appointment of Deputy General Manager of the Company
    • Dec 14, 2021: Orthofix Announces Appointment of Thomas A. West to Board of Directors
    • Dec 03, 2021: Printing Technique creates effective skin equivalent, heals wounds
    • Nov 18, 2021: Anika to Participate in Upcoming Investor Conferences
    • Nov 05, 2021: Orthofix Reports Third Quarter 2021 Results
    • Nov 04, 2021: Anika Reports Third Quarter 2021 Financial Results
    • Nov 03, 2021: Orthofix Announces Participation in Upcoming Credit Suisse and Stifel Healthcare Conferences
    • Nov 02, 2021: MIMEDX Announces Third Quarter 2021 Operating and Financial Results
    • Nov 01, 2021: Anika Appoints Sheryl Conley to Board of Directors
    • Oct 27, 2021: Orthofix Schedules Third Quarter Earnings Release and Conference Call for November 5, 2021
    • Oct 18, 2021: Anika to Issue Third Quarter 2021 Financial Results on Thursday, November 4, 2021
    • Oct 14, 2021: SINTX Technologies Shares Q3 2021 Revenue Update
    • Oct 14, 2021: MIMEDX to Host Virtual Investor Day on December 7, 2021
    • Sep 23, 2021: Orthofix Announces Appointment of Wayne Burris to Board of Directors
    • Sep 20, 2021: Orthofix Announces Participation in Upcoming Sidoti Virtual Investor Conference
    • Sep 07, 2021: Anika to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
    • Aug 03, 2021: MIMEDX Announces Second Quarter 2021 Operating and Financial Results
    • Jul 29, 2021: Smith+Nephew Second Quarter and First Half 2021 Results
    • Jul 29, 2021: Smith & Nephew announces Half-year Report
    • Jul 28, 2021: Orthofix Schedules Second Quarter Earnings Release and Conference Call for August 6, 2021
    • Jul 20, 2021: MIMEDX to Host Second Quarter 2021 Operating and Financial Results Conference Call on August 4
    • Jul 19, 2021: Anika to Issue Second Quarter 2021 Financial Results on Thursday, August 5, 2021
    • Jul 07, 2021: Timing of Smith+Nephew Second Quarter Trading and First Half 2021 Results
    • Jun 15, 2021: New study demonstrates potential for MIMEDX Purion processed dehydrated human amnion/chorion membrane to modulate pathological scar tissue formation
    • Jun 10, 2021: Worcester Polytechnic Institute Names Andrew Aberdale Board Chair
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.